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ABSTRACT
Objective: Tumor-stroma proportion of tumor has been presented 
as a prognostic factor in some types of adenocarcinomas, but there 
is no information about squamous cell carcinomas and laryngeal 
carcinomas. 
Material and Method: Five digital images of the tumor sections were 
obtained from 85 laryngeal carcinomas. Proportion of epithelial 
tumor component and stroma were measured by a software tool, 
allowing the pathologists to mark 205.6 µm2 blocks on areas as 
carcinomatous/stromal, by clicking at the image. Totally, 3.451 mm2 
tumor areas have been marked to 16.785 small square blocks for each 
case.  
Results: Median follow up was 48 months (range 3-194). The mean 
tumor-stroma proportion was 48.63+18.18. There was no difference 
for tumor-stroma proportion when tumor location, grade, stage and 
perinodal invasion were considered. Although the following results 
were statistically insignificant, the mean tumor-stroma proportion 
was the lowest (37.46±12.49) for subglottic carcinomas, and it 
was 52.41±37.47, 50.86+19.84 and 44.56±16.91 for supraglottic, 
transglottic and glottic cases. The tumor-stroma proportion was lowest 
in cases with perinodal invasion and the highest in cases without 
lymph node metastasis (44.72±20.23, 47.77±17.37, 50.05±17.34). 
Tumor-stroma proportion was higher in the basaloid subtype 
compared with the classical squamous cell carcinoma (53.76±14.70 
and 48.63±18.38 respectively). The overall and disease-free survival 
analysis did not reveal significance for tumor-stroma proportion 
(p=0.08, p=0.38). Only pathological stage was an independent factor 
for overall survival (p=0.008). 
Conclusion: This is the first series investigating tumor-stroma 
proportion as a prognostic marker in laryngeal carcinomas proposing 
a new method, but the findings do not support tumor-stroma 
proportion as a prognostic marker.  
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ÖZ
Amaç: Tümör-stroma oranı bazı adenokarsinom tiplerinde kötü 
prognostik faktör olarak tanımlanmış olmakla birlikte skuamöz 
hücreli karsinomlarda ve özellikle de laringeal karsinomlarda 
tümör-stroma oranı ile ilgili araştırma bulunmamaktadır.  
Gereç ve Yöntem: Seksen beş larenjektomi materyalinin tümörü 
örnekleyen kesitlerinden 5 dijital görüntü kaydedildi. Tümör-stroma 
oranı bu görüntülerde bilgisayar programının 205,6 µm2 
büyüklüğünde küçük kareler oluşturması ve patoloğun bilgisayar 
faresinde sol/sağ tıklama ile her bir alanı tümör ya da stroma olarak 
seçmesini sağlayan bir bilgisayar yazılım programı ile hesaplandı. 
Toplamda her olguda 16.785 tık ile 3.451 mm2 tümör alanı işaretlendi. 
Bulgular: Ortalama izlem 48 ay (3-194) ve ortalama tümör-stroma 
oranı 48,63±18,18 bulundu. Tümör yerleşimi, histolojik derecesi, 
evresi ve perinodal yayılım ile tümör-stroma oranları arasında 
anlamlı farklılık saptanmadı. İstatistiksel anlamlı sonuç elde 
edilmemiş olmakla birlikte ortalama tümör-stroma oranının 
en düşük izlendiği olgular subglottik yerleşimli olup ortalama 
oran 37,46±12,49 idi. Ortalama tümör-stroma oranı supraglottik 
olgularda 52,41±37,47, transglottik yerleşimde 50,86±19,84 ve 
glottik yerleşimde 44,56±16,91 olarak saptandı. Tümör-stroma 
oranı perinodal invazyon gösteren olgularda (44,72±20,23) düşük 
iken, perinodal invazyon bulunmayan (47,77±17,37) ve lenf nodu 
metastazı olmayanlarda 50,05±17,34 daha yüksek bulundu. Bazaloid 
skamoz hücreli karsinomlarda tümör-stroma oranı (53,76±14,70), 
klasik skuamöz hücreli karsinomdan (48,63±18,38) daha yüksek 
saptandı. Hastalıksız sağ kalım ve toplam sağ kalım ile tümör-stroma 
oranı arasında ilişki bulunmadı (p=0,08, p=0,38). Sadece patolojik 
evrenin prognostik bağımsız faktör olduğu saptandı (p=0,008).
Sonuç: Bu çalışma yeni bir yöntem eşliğinde, laringeal karsinomlarda 
tümör-stroma oranı’nın prognostik değerini araştıran ilk çalışmadır. 
Ancak bulgular tümör-stroma oranını prognostik bir belirleyici 
olarak desteklememektedir. 
Anahtar Sözcükler: Larinks tümörleri, Prognoz, Tümör, Stromal 
hücreler
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INTRODUCTION
All malignant epithelial tumors composed of epithelial cells 
are admixed with supportive tissue, named as “stroma” and 
this special tissue includes vascular-lymphatic channels and 
inflammatory cells as well as some type of fibrous tissue, 
so called desmoplasia. Desmoplastic stroma is composed 
of activated fibroblast-like cells and new extracellular 
matrix, induced by invasion of malignant cells (1,2) and 
today, it is known that the tumor stroma has an important 
role in tumor progression, invasion and metastasis (1,3,4). 
Tumor-stroma ratio or tumor-stroma proportion (TSP) 
has been presented as a prognostic factor in some types of 
carcinomas, including prostate, colorectal, esophageal and 
breast adenocarcinomas (5-11). Additionally, desmoplasia 
is presented as a poor prognostic factor in colon and lung 
adenocarcinoma (12-14) and in squamous cell carcinomas 
(SCC) of the skin and the desmoplastic variant of skin SCC 
is known as a very aggressive tumor (15-18). There is no 
information about TSP of SCC and laryngeal carcinomas, 
in particular. 
Among all cancers, carcinoma of the larynx accounts for 
2.2% in men and 0.4% in women, with an increase at the 
latter group, probably due to changing habits of smoking 
(19). Most of the laryngeal carcinomas originate from 
the supraglottic and glottic region. Although glottic 
carcinomas frequently remain localized for a long time, 
supraglottic and subglottic carcinomas tend to spread 
into the pre-epiglottic region and pyriform sinus as well 
as base of the tongue and subglottic SCC may spread to 
the thyroid gland, hypopharynx, esophagus and tracheal 
wall. Many unfavorable prognostic factors are defined for 
laryngeal carcinomas, including advanced stage, subglottic 
localization, high microscopic grade, high number and 
size of involved lymph nodes, and presence of extranodal 
extension, epidermal growth factor receptor expression, 
tumor budding and DNA aneuploidy (20-25). In this study 
the prognostic value of TSP is investigated in laryngeal SCC 
for the first time, in a series of patients treated with surgery 
and radiotherapy. 
MATERIAL and METHODS
Eighty-five patients with laryngeal carcinoma who were 
evaluated in this study were all diagnosed and treated at 
Dokuz Eylül University Hospital and had complete follow-
up information. Patients were treated by partial or total 
laryngectomy and neck dissection, followed by adjuvant 
radiotherapy and close/involved margins or neck involved 
with multiple nodes or perinodal invasion patients received 
concomitant cisplatin-based chemotherapy.
Age, gender, tumor location, clinical tumor stage and lymph 
node stage, type of surgery, pathological tumor and lymph 
node stage and the number of metastatic lymph nodes, 
perinodal invasion, tumor grade, treatment scheme with 
radio/chemotherapy time and localization of loco/regional 
recurrence and distant metastasis were determined from 
the medical records of the patients. Second primary tumors, 
time of disease-related and all-cause death, and the date of 
the last follow-up time were recorded.
Histopathological evaluation
Hematoxylin and eosin (H&E) stained sections of the 
patients with SCC were re-evaluated and 5 digital images 
were taken from adjacent tumor areas including deepest 
invasive margin, from the regions with most abundant 
stromal component, for each case by a 3-CCD color video 
camera (Olympus DP70, Olympus Optical Co. Ltd., Tokyo, 
Japan), connected to a light microscope (Olympus BX51, 
Olympus Optical Co. Ltd., Tokyo, Japan) at an original 
magnification of x20 and they were stored at a personal 
computer, only excluding large necrotic regions. 
Image Analysis
TSP was measured at the images mentioned above by a 
novel software tool developed in C++ with a Graphical 
User Interface for the Windows operating system 
Histopathological Image Atlas Editor (HIAE), allowing the 
pathologists to mark square blocks of the target area in two 
types by left or right clicking by mouse and automatically 
calculating the proportion of the marked areas. The two 
types were tumor or stroma in this study. The area of square 
regions, delineated by the software program automatically, 
which could be marked by the pathologist, was 205.6 
µm2. The final result for each case was calculated by the 
mean of the TSP’s of five images which were obtained by 
examining a 3.451 mm2 area which corresponds to 16.785 
square blocks in total. The selection of each case took about 
fifteen minutes. A screen snapshot of the HIAE is presented 
in Figure 1. In this figure, the main window of the HIAE 
displaying a histopathology slide under examination is 
presented. Individual square regions that were marked by 
the expert were merged and framed onto the image and 
also the coverage percentage of the markings was presented 
by a pie chart. In this case, the areas selected as red are the 
tumor and the yellow are stromal components. 
Statistical analysis
The cases were grouped by TSP as low and high according 
to the mean of the TSP values of all the cases. Statistical 
analysis was conducted by Scientific Package for Social 
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Sciences (SPSS 11). For comparison of these groups, 
nonparametric tests such as chi-Square were applied. The 
overall and disease free survival analysis was plotted by the 
Kaplan Meier method. For comparison of the survival of 
different groups, the log rank test was applied for unvaried 
analysis with 95% confidence interval and Cox-regression 
for multivariate analysis. Localization of tumor, clinical 
and pathological, tumor and lymph node stage, number 
of metastatic lymph nodes, perinodal invasion, and 
differentiation were evaluated as variables.
RESULTS
The study population consisted of 81 (95.3%) males and 4 
(4.7%) females. The mean age of the patients was 57 years 
(range, 36–86 years). Eight (9.4%) patients underwent partial 
and 77 patients (90.6%) underwent total laryngectomy. 
Eighty-one patients had classical SCC and 4 (4.7%) were 
of the basaloid subtype. Some clinical and prognostic 
features are given in Table I. Thirty-five cases (41.2%) 
were supraglottic, 27 (31.8%) were glottic, 4(4.7%) were 
subglottic, and 19 (22.4%) were transglottic. Pathological 
T stages were as follows: T2 for 5 patients (5.9%), T3 for 41 
patients (48.2%), and T4 for 39 patients (45.9%). Thirty-one 
patients (48.2%) had no lymph node metastasis (pN0), and 
the numbers of pN1, pN2, and pN3 cases were 18 (21.2%), 25 
(29.4%), and 1 (1.2%) respectively. Twenty patients (23.5%) 
had perinodal invasion. All patients were considered for 
post-operative radiotherapy for the following reasons: pT 
stages 3 and 4, pN (+), patients with pT2 and a positive 
surgical margin, and/or subglottic extension. All patients 
received adjuvant radiotherapy, and received concomitant 
chemotherapy according to the criteria described above.
Median follow up was 48 months (range 3-194). The mean 
TSP was 48.63+18.18. There was no difference for TSP when 
sex, tumor location, tumor grade, pathological and clinical 
tumor and lymph node stage, and perinodal invasion 
were considered (p=0.36, p=0.21,p=0.24, p=0.41, p=0.40, 
p=0.83, respectively). Although statistically insignificant, 
the mean TSP was the lowest for subglottic carcinomas 
compared with supraglottic, transglottic and glottic cases 
(37.46+12.49, 52.41+37.47, 50.86+19.84 and 44.56+16.91, 
respectively). Also TSP was lowest in cases with perinodal 
invasion compared with cases with metastasis but no 
perinodal invasion and highest in cases without lymph 
node metastasis (44.72+20.23, 47.77+17.37, 50.05+17.34, 
respectively). The mean value of TSP was higher in basaloid 
subtype compared with the classical SCC cases (53.76±14.70 
and 48.63±18.38, respectively). 
The overall and disease free survival analysis did not reveal 
significance with log rank for sex, tumor location, tumor 
grade, clinical tumor and pathological lymph node stage, 
and perinodal invasion as well as TSP, but significance for 
clinical lymph node stage (p=0.036), pathological T stage 
Figure 1: An 
image sample of 
selected tumor area 
with the software 
Histopathological 
Image Atlas Editor.
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DISCUSSION
Recent findings highlight the importance of TSP as a 
prognostic marker in some types of cancer (5-11). High 
proportion of stroma seems to be a poor prognostic marker 
(5-11). 
(p=0.01), pathological stage (p=0.016) and number of 
metastatic lymph nodes (p=0.00) (Figure 2, Table II). Only 
pathological stage was an independent factor with cox-
regression for overall survival with 95% confidence interval 
(p=0.008, hazard ratio=1.003; lower: 1.001, upper: 1.005) 
among the latter four features with statistical significance.
Table I: Demographical and prognostic distributions of all cases according to proportion of tumor-stroma
 Proportion of tumor-stroma
   All cases     High    Low 
n % n % n % P value
Gender              0.36
Male 81 95.3 39 48 42 52
Female 4 4.7 1 25 3 75
Location 0.21
Glottic 27 31.8 9 22.5 18 40
Supraglottic 35 41.2 19 47.5 16 35.6
Subglottic 4 4.7 1 2.5 3 6.7
Transglottic 19 22.4 11 27.5 8 17.8
Grade  0.24
 well 24 28.4 13 32.5 11 24.4
 moderate 42 49.4 20 50 22 48.9
 poor 19 22.4 7 17.5 12 26.7
pT  0.41
pT1 0 0 0 0 0 0
pT2 5 6 1 2.5 4 9
pT3 41 48 21 52.5 20 44.4
pT4 39 46 18 45 21 47
pN 0.40
pN0 41 48.2 20 48.8 21 46.7
pN1 18 21.2 11 27.5 7 15.6
pN2a 4 4.7 1 2.5 3 6.7
pN2b 16 18.8 5 12.5 11 24.4
pN2c 5 5.9 3 7.5 2 4.4
pN3 1 1.2 0 0 1 2.2
Pericapsular invasion              0.83
Yes 20 23.5 9 22.5 11 24.4
No 65 76.5 31 77.5 34 75.6
Local Recurrence 0.90
Yes 4 5 2 5 2 4
 No 81 95 38 95 43 96
Distant recurrence 0.82
Yes 12 14.1 6 15.0 6 13.3
No 73 85.9 39 53.4 34 46.6
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Table II: Overall survival analysis with Log rank and “p” value. The standard error was calculated with 95% confidence interval
3 year overall 
survival rate  P value Mean Std. Error Lower bound Upper bound
TSP
< 48.63
>48.63
43%
50%
0.381
113
133
12
15
89
103
136
163
Gender
Male
Female
78%
50%
0.088
124
38
9
13
105
11
143
65
Location
Glottic
Supraglottic
Subglottic
Transglottic
39%
33%
50%
71%
0.720 113
111
141
107
13
15
34
13
87
81
74
81
139
141
208
134
Clinical tumor stage
T2
T3
T4
73%
84%
82%
0.748
129
126
89
23
12
11
82
102
67
175
150
111
Clinical N stage
N0
N1
N2
75%
51%
80%
0.008
131
38
97
10
8
23
110
21
52
152
55
143
Clinical stage
Stage II
Stage III
Stage IV
78%
85%
82%
0.187
109
137
99
16
13
14
76
110
70
142
163
128
Pathological tumor 
stage
T2
T3
T4
100%
81%
85%
0.010 136111
128
0.7
13
14
134
85
100
137
137
157
Pathological N stage
   N0
   N1
   N2 
42%
87%
74%
0.370
118
121
107
8
22
17
101
77
74
136
165
141
Pathological stage
   Stage II
   Stage III
   Stage IV
100%
87%
82%
0.016
136
115
122
0.7
15
12
134
85
98
137
145
146
Perinodal invasion
   +
    -
82%
84%
0.534
102
124
16
11
69
102
136
146
Grade
  I
  II
  III
86%
88%
66%
0.434
139
102
116
15
11
21
109
80
73
169
124
159
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myofibroblastic cell proliferation (31,32). Myofibroblasts 
are derived either from the bone-marrow or the multiple 
resident precursors; the endothelial cells, smooth muscle 
cells, adipocytes and stellate cells (29). 
Recently tumor stromal cells have been shown to 
participate in the Warburg effect in a reverse pattern, 
through the stimulation of the hydrogen peroxide secretion 
by the tumor cells inducing pseudohypoxia in the tumor 
microenviroment. The stromal cells then produce and 
present L-lactate and ketone as well as nucleotides, fatty 
acids and amino acids, such as glutamine to the tumor 
cells as a result of aerobic glycolysis and mitophagy (33,34). 
All these above mentioned data support the stroma as an 
important predictor of tumor behavior. 
The association of hypoxia, fibrosis and poor prognosis 
has been recognized in various tumors for some time (35). 
The production of more growth factors by more stromal 
cells and the encapsulation of the tumor cells by fibrosis 
not allowing the penetration of the immune response 
were proposed to explain this association along with the 
mechanisms described above (32,33,37,38). Depending 
upon all these findings, the morphological quality and 
quantity of tumor stroma is evaluated in different tumors 
as prognostic markers. The properties of the stroma are 
described as a prognostic marker in rectal cancer by Ueno 
et al who proposed mature, intermediate and immature 
categories (12). They identified more tumor budding, which 
is also a poor prognostic factor in colorectal carcinomas 
as well as poor prognosis in cases with immature stroma 
(12,38,39). 
The quantity of stroma or stromal components was 
also described as prognostic features. Sis et al. reported 
desmoplasia measured by computer assisted image analysis 
in van Gieson stained sections as a poor prognostic factor 
in colorectal carcinoma (13). Mesker et al. proposed 
carcinoma stroma ratio as a prognostic marker in 
colorectal carcinomas (6). They estimated the TSP in tumor 
sections and the scored lowest percentage was considered 
as decisive. In this study, 50% was accepted as the cutoff 
point for dichotomatous categorization, and they identified 
tumor percentage as an independent prognostic factor in 
Cox regression analysis. This was followed by the study in 
oesophageal adenocarcinoma by Courrech Staal et al., the 
same method was applied but in this study “tumor-stroma 
ratio” terminology was used instead of percentage and the 
tumor stroma ratio was identified as a highly significant 
prognostic factor (9). Moorman et al (10) and de Kruijf et 
al. (8) presented the prognostic value of tumor-stroma ratio 
in triple negative breast adenocarcinomas with methods 
The importance of tumor-stroma interaction was 
recognized a long time ago. Stephan Paget, a surgeon and 
son of Sir James Paget who is recognized as the founder of 
scientific medical pathology, proposed the “seed and soil” 
hypothesis in 1889. He concluded that “the best work in 
pathology of cancer is done by who are studying the nature 
of the seed (the cancer cell); the observations of the soil 
(the secondary organ) may also be useful” (26). During the 
last three decades there is increasing evidence that support 
the role of tumor stroma in tumor invasion, metastasis, 
progression and prognosis. 
In 1993 Dingemans et al. presented the infiltrative 
phenotype of colon carcinoma cells when transplanted into 
granulation tissue while they formed encapsulated and well 
differentiated tumors at undisturbed subcutaneous tumors 
in an experimental model (27). This study presented 
direct evidence for the importance of tumor stroma in the 
prognostic phenotypical features of tumor growth like the 
infiltrative pattern. Many other factors about tumor stroma 
have also been described. The tumor microenvironment 
consists of extracellular matrix, immune and inflammatory 
cells, blood vessel cells and myofibroblasts (28). The 
myofibroblasts, fibroblastic cells adjacent to cancer cell 
nests expressing α-smooth muscle actin, seem to be very 
important contributors of the tumor stroma through the 
secretion of matrix metalloproteinases (MMP) and their 
inhibitors (TIMP), cytokines and chemokines along with 
the neoplastic cells (29). Degradation of the matrix and 
the MMPs are crucial for invasion and metastasis (30). It is 
suggested that platelet-derived growth factor (PDGF) and 
transforming growth factor-β (TGF-β) expression induce 
Figure 2: Graphic for overall survival.
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grade, tumor and lymph node stage were not identified 
as prognostic factors as well as TSP and only pathological 
stage was an independent prognostic factor for overall 
survival. Although there are conflicting results about SCC 
of the larynx in terms of desmoplasia, histopathological 
prognostic features and prognosis, considering the results 
in this series it is hard to conclude that the TSP is not a 
prognostic marker in laryngeal carcinomas (40-42). 
Although statistically insignificant, the lower TSP identified 
associated with lymph node metastasis and perinodal 
invasion as well as subglottic localization, which are poor 
prognostic factors in laryngeal carcinomas, suggests that 
further evaluation may provide significant results. 
It seems TSP is an important factor that needs further 
evaluation in SCC as well as adenocarcinomas. Although 
we could not find statistical significance in this series for 
TSP, the quantitative method described in this series might 
be helpful for determining TSP in other series. 
REFERENCES
1. De Wever O, Mareel M: Role of tissue stroma in cancer cell 
invasion. J Pathol 2003, 4:429-447
2. Ohtani H: Stromal reaction in cancer tissue: Pathophysiologic 
significance of the expression of matrix-degrading enzymes in 
relation to matrix turnover and immune/inflammatory reactions. 
Pathol Int 1998, 1:1-9 
3. Halvorsen TB, Seim E: Association between invasiveness, 
inflammatory reaction, desmoplasia and survival in colorectal 
cancer. J Clin Pathol 1989, 2:162-166
4. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley 
DR: Reactive stroma in human prostate cancer: Induction of 
myofibroblast phenotype and extracellular matrix remodeling. 
Clin Cancer Res 2002, 9: 2912-2923
5. Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles BJ, 
Wheeler TM, Ayala GE: Stromogenic prostatic carcinoma 
pattern (carcinomas with reactive stromal grade 3) in needle 
biopsies predicts biochemical recurrence-free survival in patients 
after radical prostatectomy. Hum Pathol 2007, 11:1611-1620
6. Mesker WE, Junggeburt JM, Szuhai K, de Heer P, Morreau H, 
Tanke HJ, Tollenaar RA: The carcinoma-stromal ratio of colon 
carcinoma is an independent factor forsurvival compared to 
lymph node status and tumor stage. Cell Oncol 2007, 5:387-398
7. West NP, Dattani M, McShane P, Hutchins G, Grabsch J, Mueller 
W, Treanor D, Quirke P, Grabsch H: The proportion of tumour 
cells is an independent predictor for survival in colorectal cancer 
patients. Br J Cancer 2010, 10:1519-1523
8. de Kruijf  EM, van Nes JG, van de Velde CJ, Putter H, Smit VT, 
Liefers GJ, Kuppen PJ, Tollenaar RA, Mesker WE: Tumor-stroma 
ratio in the primary tumor is a prognostic factor in early breast 
cancer patients, especially in triple-negative carcinoma patients. 
Breast Cancer Res Treat 2011, 3:687-696 
similar to Mesker et al (6). The importance of the tumor 
stroma ratio is also validated by the morphometric study by 
West et al. in colorectal adenocarcinomas (7). 
The above mentioned findings are in favor of TSP as 
a prognostic factor for adenocarcinomas, but there is 
no information about SCC other than articles about 
desmoplasia. The association of desmoplastic response 
and unfavorable prognostic histopathological findings 
and recurrences were described for skin SCC (14-17). de 
Diego SJI (40) could not detect any relationship between 
desmoplasia with local recurrence in laryngeal and 
hypopharyngeal carcinomas, but Prim et al. (41) presented 
the desmoplasia at metastatic lymph nodes as a prognostic 
marker. Zidar et al. reported well differentiated SCC 
morphology and desmoplasia association in laryngeal 
SCC but they did not present prognostic data (42). Tumor 
budding, a poor prognostic finding related to the type of 
desmoplasia in colorectal carcinomas, is also described as 
a prognostic marker for laryngeal SCC (12,25). Based on 
the lack of information about TSP in laryngeal carcinomas 
and the above mentioned findings, we investigated if there 
was any relationship between TSP and histopathological 
findings and survival in laryngeal SCC. 
Two methods were applied in the previous series in order 
to determine TSP. de Kruijf et al. (8), and Courrech Staal et 
al. (9) applied the methodology described by Mesker WE 
et al. (6), and they used semiquantitative measurements 
depending upon the estimation of the pathologists by 
visual inspection, while West et al. (7) performed point 
counting with a grid of 300 points and counted tumor-
stroma proportion in a 9 mm2 tumor region. While the 
former authors had selected the deepest invasive border of 
the neoplastic lesions at the most stroma rich regions, West 
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